利福昔明FDA批准片剂Ⅲ期临床试验药业上市复发风险安慰剂对照Xifaxan 550mg片剂获得批准用于降低≥18岁患者的肝性脑病(hepatic encephalopathy,HE)复发的风险.此项批准是基于一项在299例患者中进行的双盲,安慰剂对照,国际多中心Ⅲ期临床试验.该试验证明Xifaxan@550mg片剂在统计学上和临床上均可显著降低HE复发风险.中国新药...
XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy recurrence and for the treatment of IBS-D in adults. See Important Safety Information and full Prescribing Information on website.
960化工网为您提供利福昔明 rifaximin Xifaxan 550mg 批件转让商品详情介绍,价格,品牌,产地,供应商详情,产品属性等详见960化工网产品详情页。找生物产品, 上960化工网,全国免费电话4000-025-960
Xifaxan Zaxine Ther. Class. anti-infectives Pharm. Class. rifamycins Indications Indications Indications Travelers' diarrhea due to noninvasive strains ofEscherichia coli. Reduction in risk of overt hepatic encephalopathy recurrence. Treatment of irritable bowel syndrome with diarrhea ...
Xifaxan Zaxine Ther. Class. anti-infectives Pharm. Class. rifamycins Indications Indications Indications Travelers' diarrhea due to noninvasive strains of Escherichia coli. Reduction in risk of overt hepatic encephalopathy recurrence. Treatment of irritable bowel syndrome with diarrhea Action Action Actio...
rifAXIMin Routes Dosage Forms Strengths Brand Names Manufacturer Oral Tablets 200 mg Xifaxan Salix 550 mg Xifaxan Salix AHFS DI Essentials™. © Copyright 2025, Selected Revisions December 10, 2024. American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, ...
Xifaxan Pharmacologic class:Rifampin-related antibiotic Therapeutic class:Anti-infective Pregnancy risk category C Action Binds to beta-subunit of bacterial DNA-dependent RNA polymerase, inhibiting bacterial RNA synthesis Availability Tablets:200 mg, 550 mg ...
200 mg, 550 mg oral tablets How should I store Xifaxan? Xifaxan should be stored at room temperature, between 68 F to 77 F (20 C to 25 C). It can be exposed to temperatures between 59 F to 86 F (15 C to 30 C), for shorter periods of time, such as when transporting it. Sto...
US-FDA Label of Xifaxan 200 mg tablets May 21, 2004, 13 pages. Zaxine SmPC Sep. 2000, 10 pages. Summons to attend Oral Proceedings issued on May 23, 2016 for the Application N. EP07804680.2. 6 pages. Response to the summons to attend Oral Proceedings filed by the Applicant on Oc...
FDA Approves XIFAXAN(R) (rifaximin) 550 Mg Tablets For The Treatment Of Hepatic Encephalopathy